30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Craig Stapleton

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 70% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Non-Executive Independent Chairman of the Board Avadel Pharmaceuticals PLC July 1, 2014 - May 9, 2019
Independent Director Abercrombie & Fitch Co Jan. 27, 2014 - June 1, 2017
Independent Director Avadel Pharmaceuticals PLC June 24, 2011 - July 1, 2014
Lead Independent Director Abercrombie & Fitch Co Feb. 23, 2010 - Jan. 27, 2014
Craig Stapleton's trades of Avadel Pharmaceuticals PLC's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2017-09-14 2017-09-12
B Purchase
56,988 -45.3%
384.85
US$3,342,575 		56,988 -45.3% 384.85 US$3,342,575
2016-11-30 2016-11-29
B Purchase
51,335 -28.6%
405.11
US$536,090 		51,335 -28.6% 405.11 US$536,090
2016-09-06 2016-09-01
B Purchase
56,855 +33.6%
400.20
US$2,106,982 		56,855 +33.6% 400.20 US$2,106,982
2016-08-29 2016-08-26
B Purchase
9,122 +83.9%
13.67
US$124,698 		9,122 +83.9% 13.67 US$124,698
2016-08-29 2016-08-26
B Purchase
10,878 +inf%
13.83
US$150,443 		10,878 +inf% 13.83 US$150,443
2016-03-16 2016-03-14
B Purchase
100,000 +26.1%
10.39
US$1,039,400 		100,000 +26.1% 10.39 US$1,039,400